Skip to content

Clinical trials

Terminated Multiple Endocrine Neoplasia Type 1 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Endocrine Neoplasia Type 1 Status: Terminated Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20131
20172

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre Hospitalier Universitaire de Saint Etienne1
M.D. Anderson Cancer Center1
Novartis Pharmaceuticals1
UNC Lineberger Comprehensive Cancer Center1
Yale University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Endocrine Neoplasia Type 15
Arthritis1
Atherosclerosis1
Breast Neoplasms1
Infertility1
Meningioma1
Neuroendocrine Tumors1
Obesity1
Prostatic Neoplasms1
von Hippel-Lindau Disease1

Trials

Showing 26 to 5 of 5. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.